[The pure red cell aplasia in children (observation 2010-2012 years)]

Z Mtvarelidze1, A Kvezereli-Kopadze, M Kvezereli-Kopadze

  • 1Children's New Clinic, Tbilisi, Georgia.

Georgian Medical News
|April 10, 2013
PubMed

Insights

This study investigated pediatric pure red cell aplasia (PRCA), including Diamond-Blackfan anemia (DBA). Comprehensive diagnostics identified DBA and acquired PRCA causes, with most children achieving remission.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Genetics

Background:

  • Pure red cell aplasia (PRCA) is a rare disorder characterized by the selective suppression of erythropoiesis.
  • Congenital PRCA, such as Diamond-Blackfan anemia (DBA), and acquired PRCA have distinct etiologies and clinical presentations.
  • Understanding the diagnostic workup and management of pediatric PRCA is crucial for effective treatment.

Observation:

  • Four children aged 1 month to 3 years with PRCA underwent extensive investigations.
  • Diagnostic procedures included complete blood count, bone marrow examination, iron metabolism, viral serologies, immunological analysis, and specific assays.
  • Clinical and paraclinical data analysis led to diagnoses of DBA and acquired PRCA, with identified triggers including EBV virus and transient erythroblastopenia.

Findings:

  • Two cases were diagnosed with Diamond-Blackfan anemia (DBA).
  • Two cases were diagnosed with acquired PRCA, one attributed to EBV virus and the other to transient erythroblastopenia.
  • Currently, three children with PRCA are asymptomatic, indicating potential for remission.

Implications:

  • PRCA requires a tailored diagnostic and therapeutic approach due to its rarity and varied causes.
  • Comprehensive investigations are essential to determine the specific etiology of PRCA.
  • Early diagnosis and appropriate management strategies can lead to favorable outcomes in pediatric PRCA patients.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...